98 related articles for article (PubMed ID: 22394627)
1. [Study on combined immunization of rAd/MDC-VP1 and pcDNA3/MDC-VP1 against Coxsackievirus B3 challenge in mice].
Yan LJ; Gao ZY; Li J; Lan JM; Jin YH; Xie LX; Chuai X; Wang YX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):228-31. PubMed ID: 22394627
[TBL] [Abstract][Full Text] [Related]
2. [Immune effects of four coxsackievirus B3 VP1 DNA fusion vaccines in mice].
Liu GX; Lan JM; Chuai X; Gao ZY; Jin YH; Zhang YH; Xie LX; Yin CF; Wang YX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):103-6. PubMed ID: 20230664
[TBL] [Abstract][Full Text] [Related]
3. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
[TBL] [Abstract][Full Text] [Related]
4. [C3d enhances immune response to the secreted form of Coxsackie virus B3 VP1 DNA vaccine].
Zhao N; Han XY; Wang XL; Li J; Li W; Xie LX; Li L; Wang YX
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2561-3. PubMed ID: 18067834
[TBL] [Abstract][Full Text] [Related]
5. [The effects of inoculation route and adjuvant type on the immunizing potency of CVB3 VP1 protein].
Wen C; Gao ZY; Lan JM; Yan LJ; Chuai X; Li J; Li W; Wang YX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1086-9. PubMed ID: 21968309
[TBL] [Abstract][Full Text] [Related]
6. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
Yue Y; Xu W; Hu L; Jiang Z; Xiong S
Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
[TBL] [Abstract][Full Text] [Related]
8. [Protective immunoresponse to CVB3 induced by gene immunization with pcDNA3-VP1].
Xu W; Shen Y; Wang LX; Xu CF; Zheng XJ; Xiong SD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 May; 19(3):239-41. PubMed ID: 15155081
[TBL] [Abstract][Full Text] [Related]
9. [A novel DNA vaccine containing endosome-fusogenic peptide prevents CVB3-induced myocarditis in mice].
Xu W; Shen Y; Chen RZ; Xiong SD
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):334-8. PubMed ID: 15059520
[TBL] [Abstract][Full Text] [Related]
10. Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice.
Yu M; Qiu Y; Chen J; Jiang W
Virus Genes; 2016 Apr; 52(2):228-34. PubMed ID: 26837895
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.
Xu W; Shen Y; Jiang Z; Wang Y; Chu Y; Xiong S
Vaccine; 2004 Sep; 22(27-28):3603-12. PubMed ID: 15315839
[TBL] [Abstract][Full Text] [Related]
12. [Construction of the recombinant adenovirus expressing the CVB3 sVP1-C3d3 protein and study on its immunological effects in mice].
Li J; Li J; Xian X; Liu GX; Lan JM; Jin YH; Xie LX; Zhang H; Wang YX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):47-50. PubMed ID: 21208565
[TBL] [Abstract][Full Text] [Related]
13. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice.
Jiang W; Jiang P; Li Y; Tang J; Wang X; Ma S
Vet Immunol Immunopathol; 2006 Sep; 113(1-2):169-80. PubMed ID: 16777236
[TBL] [Abstract][Full Text] [Related]
15. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
Yin L; Chai D; Yue Y; Dong C; Xiong S
Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
[TBL] [Abstract][Full Text] [Related]
16. Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice.
Chunling M; Kun Y; Jian X; Jian Q; Hua S; Minsheng Z
Intervirology; 2006; 49(5):307-18. PubMed ID: 16809936
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus.
Jiang W; Jiang P; Wang X; Li Y; Du Y; Wang X
Virus Res; 2008 Sep; 136(1-2):50-7. PubMed ID: 18538882
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice.
Henke A; Chiang CS; Zell R; Stelzner A
Antiviral Res; 2004 Nov; 64(2):131-6. PubMed ID: 15498609
[TBL] [Abstract][Full Text] [Related]
19. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.
Du Y; Jiang P; Li Y; He H; Jiang W; Wang X; Hong W
Vaccine; 2007 Nov; 25(49):8209-19. PubMed ID: 17980939
[TBL] [Abstract][Full Text] [Related]
20. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
